Media Coverage

News featured in WholeFoods Magazine

Mr. Shaheen Majeed, President Worldwide of Sabinsa and Dr. N. Kalyanam, President R&D for Sami-Sabinsa Group in conversation with WholeFoods Magazine regarding the power of herbs and their role in cardiovascular health

On the manufacturer side, Shaheen Majeed, President Worldwide of Sabinsa (owner of and manufacturer for America’s Finest, Inc. and Sanutra), adds that two ingredient-specific formulas can be found with the AFI label, and a comprehensive cardio and cholesterol support formula in its Sanutra line: AFI Silbinol offers 450 mg of Indian Kino Tree (Pterocarpus marsupium) extract, providing 22.5 mg of Pterostilbene per vegetarian capsule. Majeed says pterostilbene is an antioxidant compound, chemically similar to resveratrol, but more bioavailable and efficacious, and is also recognized for reducing LDL cholesterol in numerous clinical studies...

Read more... 

 

    HEADQUARTERS

  • Sami-Sabinsa Group
    19/1 & 19/2, Ⅰ Main, Ⅱ Phase
    Peenya Industrial Area
    Bangalore - 560 058
    Karnataka, India

  • +91 80 6852 7706
  • info@sami-sabinsagroup.com

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.